Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

typhoid fever - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

typhoid fever

MONDO:0005619

Also known as:typhoidtyphoidal salmonellosis

Find Clinical TrialsTrials

Overview

A bacterial infectious disorder contracted by consumption of food or drink contaminated with Salmonella typhi. This disorder is common in developing countries and can be treated with antibiotics.

Treatments1 FDA approved

Clinical Trials10 registered · 2 recruiting

Diagnosis

Biomarker and diagnostic research for typhoid fever has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

1 FDA-approved treatment is available for typhoid fever, including CIPROFLOXACIN (CIPRO, approved 1997).

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Prognosis

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

10 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, biologic therapy, and other interventions. Pipeline includes 3 PHASE4, 2 PHASE3, 1 EARLY_PHASE1. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT03705585](https://clinicaltrials.gov/study/NCT03705585)

Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 6:09 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:99745

GARD

Genetic and Rare Diseases Info Center

GARD:9564

Questions for Your Care Team

→What are the benefits and potential side effects of CIPRO for managing typhoid fever?
→Are any of the 10 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Disease patterns and progression	50	35%
Laboratory research	28	19%
Research summaries	25	17%
Clinical study results	16	11%
Patient case studies	13	9%
Testing and diagnosis research	9	6%
New treatment approaches	3	2%

typhoid fever

Overview

Diagnosis

Treatment

Approved Therapies

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications